Myopia is advancing rapidly among children worldwide, and a new randomized clinical trial in the United States suggests that specially designed spectacle lenses may slow the biological changes that drive the condition. Published in JAMA Ophthalmology, the study found that lenses containing highly aspherical lenslets, known as HAL, reduced both myopia progression and axial elongation over a 24-month period. The findings add to growing evidence that ordinary prescription glasses can be redesigned not only to correct blurred vision but also to influence how the developing eye grows.
Myopia, or nearsightedness, occurs when the eye becomes optically too powerful for its length, causing distant objects to appear blurred. In children, the most important structural change is usually progressive elongation of the eyeball from front to back. Glasses can restore clear vision by compensating for this optical mismatch, but conventional single-vision lenses do not generally alter the underlying growth pattern. Excessive axial elongation is clinically important because higher levels of myopia are associated later in life with increased risks of retinal detachment, myopic maculopathy, glaucoma and other vision-threatening disorders.
The HAL lenses tested in the trial use a central optical zone for clear distance vision surrounded by numerous tiny lenslets with highly aspherical surfaces. These lenslets are designed to create a controlled pattern of light in front of the retina while maintaining functional vision through the central portion of the lens. The optical signal is intended to reduce the stimulus for the eye to continue lengthening. This approach differs from simply reducing the strength of a child’s prescription: it attempts to provide clear vision and a secondary myopia-control signal at the same time.
The study was conducted as a randomized clinical trial involving children in the United States. Participants were assigned to wear spectacle lenses incorporating HAL or to a comparison lens, allowing investigators to evaluate changes under controlled conditions rather than relying only on observations from routine clinical care. Over two years, the researchers tracked refractive changes, which indicate how much myopia had progressed, as well as axial length, a direct anatomical measurement of eye growth. The trial’s two-part assessment is important because a stronger prescription alone can reflect changing optics, whereas axial elongation measures the physical expansion most closely linked to long-term risk.
According to the study summary, children wearing HAL lenses experienced less myopia progression and less axial elongation during the 24-month follow-up than children in the comparison group. The results support the idea that the retina can respond not only to whether an image is clear but also to the spatial distribution of light across the visual field. Researchers believe that these peripheral optical cues may affect biochemical signaling within the retina and choroid, ultimately influencing the sclera—the outer coat of the eye that determines its final length. The precise biological pathway remains an active area of research.
The findings are particularly relevant because childhood myopia often progresses during the years when visual habits, education and eye growth are changing most rapidly. Increased near-work demands, reduced time outdoors and genetic susceptibility have all been associated with the global rise in myopia, although no single factor explains every child’s experience. A spectacle-based intervention may be easier to adopt than treatments requiring eye drops, contact lenses or overnight corneal reshaping. Because HAL lenses are worn like ordinary glasses, they could offer families a familiar and comparatively straightforward way to incorporate myopia control into daily life.
The trial also reported that the lenses were safe over the study period, supporting their use as a clinical intervention for children who need vision correction and are at risk of progression. Safety is a central consideration in pediatric eye care because treatment may continue for years during a period of ongoing ocular development. Even when a lens is designed to create an optical treatment signal outside the central viewing area, children must still be able to read, walk, play and perform schoolwork comfortably. The study summary indicates that the overall findings contributed to authorization by the US Food and Drug Administration of the device used in the trial.
However, the investigators emphasize that longer-term data are still needed. A 24-month study can show whether a treatment changes the rate of progression over a meaningful period, but it cannot fully determine whether the benefit persists, increases, diminishes or changes after children stop using the lenses. Researchers will also need to examine outcomes across different ages, prescriptions, ethnic groups and patterns of baseline progression. The relationship between slowing axial elongation in childhood and reducing eye disease decades later is strongly plausible, but it requires continued follow-up to quantify the eventual clinical impact.
The results arrive as ophthalmologists and families search for scalable responses to the worldwide myopia epidemic. HAL lenses do not eliminate myopia, reverse existing axial elongation or replace regular eye examinations, and treatment decisions must still be individualized by eye-care professionals. Nevertheless, the randomized evidence marks an important step in the development of optical strategies that address the cause of progression rather than correcting blur alone. If sustained benefits are confirmed in longer-term studies, highly aspherical lenslet spectacles could become an increasingly visible part of pediatric eye care—and a powerful example of how precision optics may help reshape the future of vision.
Subject of Research: HAL spectacle lenses for controlling myopia progression and axial elongation in children.
Web References: https://doi.org/10.1001/jamaophthalmol.2026.3288
References: JAMA Ophthalmology. Randomized clinical trial of spectacle lenses with highly aspherical lenslets in US children. DOI: 10.1001/jamaophthalmol.2026.3288.
Keywords: Myopia, nearsightedness, children, myopia control, highly aspherical lenslets, HAL lenses, spectacle lenses, axial elongation, ophthalmology, randomized clinical trial, pediatric eye care, vision science.
